fingolimod hydrochloride has been researched along with Bladder Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azuma, H; Horie, S; Katsuoka, Y; Muto, S; Otsuki, Y; Takahara, S | 1 |
1 other study(ies) available for fingolimod hydrochloride and Bladder Cancer
Article | Year |
---|---|
Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment.
Topics: Animals; Apoptosis; Blotting, Western; Cell Division; Cell Line; Cell Survival; DNA Fragmentation; DNA, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Activation; Fibroblasts; Fingolimod Hydrochloride; Hepatocyte Growth Factor; Humans; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Transplantation; Phosphorylation; Propylene Glycols; Sphingosine; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2003 |